Notice of Intent to Sole Source.pdf
PDF 130 KB Posted
- Solicitation number
- FDA-RFQ-CFSAN-2024-122911
About this file
This document is a Notice of Intent to Sole Source for a Preventative Maintenance Agreement (PMA) for a Milestone UltraCLAVE IV Autoclave Microwave Digestion System. The Food and Drug Administration (FDA) intends to award a sole source Fixed Price Purchase Order to Milestone Inc. for a base year (12 months) with four 12-month option periods under Request for Quote FDA-RFQ-CFSAN-2024-122911. The agency has determined Milestone Inc. is the only responsible source for this requirement, as they are the only factory-trained and authorized service provider for this equipment. The associated NAICS code is 811210 Electronic and Precision Equipment Repair and Maintenance. Offerors must be registered in SAM.gov and have completed representations and certifications by the solicitation close date. This notice is not a request for competitive proposals, but any organization that believes it can meet the requirement may submit a written capability statement by the response date of 04/30/2023.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent to Sole Source
Subject: Fixed Price (FFP) Purchase Order Type for the procurement of: FDA-RFQ-CFSAN-2024- 122911-Preventative Maintenance Agreement (PMA) for a Milestone UltraCLAVE IV Autoclave Microwave Digestion System, for a base year (12 Months) and 4 (four) (12 Months) option periods, under Request for Quote FDA-RFQ-CFSAN-2024-122911, on a sole source basis.
Notice of Intent to Sole Source to: Milestone Inc.
Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, (there is only one responsible source, and no other supplies or services will satisfy agency requirements). The Food and Drug Administration (FDA) intends to award a Sole Source Fixed Price (FFP) Purchase Order Type to Milestone Inc., located at:
Milestone Inc or Distributors/Retailers Michael Quintero Service Manager T: 203-925-4240 ext. 359 F: 203-925-4241 m.quintero@milestonesci.com
FDA requires a Preventative Maintenance Agreement (PMA) for a Milestone UltraCLAVE IV Autoclave Microwave Digestion System, for a base year (12 Months) and 4 (12 Months) option periods, under Request for Quote FDA-RFQ-CFSAN-2024-122911, on a sole source basis. In a sole source letter to FDA the Vendor stated: “This letter is to confirm that Milestone Inc., is the only factory trained and authorized service provider for all Milestone Inc., equipment. In addition, Milestone Inc., is also the only authorized agent for providing service contracts. Our service contracts are inclusive of parts, labor and travel to keep the unit in working condition. We are the only distributor in the United States authorized to sell and service Milestone, Inc., equipment”. The items/services are solely distributed/provided by the manufacturer/subsidiaries and official distributors, with no thirty party re-sellers.
The associated NAICS: 811210 Electronic and Precision Equipment Repair and Maintenance.
Offerors must have an active registration in www.SAM.gov, with completed representations and certifications, by the close date of the solicitation.
This notice is not a request for competitive proposals. However, any party that believes it is capable of meeting this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. Capability statements must be mailto:m.quintero@milestonesci.com received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to Milestone Inc., within approximately fifteen (15) days after the date of this notice unless the Government determines that any other organization has the capacity to meet this requirement.
Response Date: 12:00 p.m. EST 04/30/2023. Please email responses to Emmanuel Mbah at Emmanuel.mbah@fda.hhs.gov mailto:Emmanuel.mbah@fda.hhs.gov
File details come from the government source that posted it. Updated .